We’ve Teamed Up with the American Cancer Society
American Cancer Society and Melanoma Research Alliance have united to fund lifesaving research aimed at reducing side effects and improving outcomes for patients treated with immunotherapy.
Why it Matters: U.S. Preventive Services Task Force Endorses Skin Cancer Prevention Counseling for Children and Young Adults
By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 20 May 2018 In News, Prevention
This government-backed panel just put skin cancer prevention counseling on the map.
American Cancer Society and Melanoma Research Alliance Fund Five Innovative Approaches to Reduce Immunotherapy Side Effects
As the world marks Melanoma Awareness Month, the American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) selected the first group of scientists to receive newly established research grants to investigate how to reduce rare, but serious, side effects resulting from cancer treatments with checkpoint inhibitors, a type of immunotherapy.
Melanoma Awareness Month: Opportunities to Make a Difference
By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 30 April 2018 In Prevention
Melanoma Awareness Month, held in May each year, is a wonderful opportunity to raise awareness of the dangers of melanoma, the importance of early detection, and the many ways to practice sun safety. From talking about sun safety to your friends and family, taking the Skin Check Pledge, posting about melanoma on social media, or highlighting prevention strategies in your organization newsletter—there are many ways we can all take part and make a difference!
Tackling Brain Metastases
Brain metastases (mets) are a frequent and often deadly problem in patients with advanced melanoma. Nearly 40% of patients with metastatic melanoma have brain mets at diagnosis, with an average survival of only 4 months, suggesting a crucial need for treatments that can rid the brain of these tumors1,2. But new cancer treatments are rarely tested in patients with active brain mets. This is largely due to concerns about whether these patients will have side effects unique to brain mets, and poorer outcomes that may negatively weigh against otherwise positive clinical benefits. Another potential concern is whether the drugs will even penetrate the brain, which has a fortress-like ability to keep substances from entering it.
Are Personalized Vaccines Part of a New Combination Approach to Treating Melanoma?
By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 29 April 2018 In Allies & Partnerships, Science
Bracing for cold weather and the threat of runny noses and sore throats, millions of Americans are vaccinated for the flu each year. By priming the immune system, the vaccine reduces the risk of catching the flu and, if not successful at preventing it altogether, reduces both the severity and the duration of symptoms. These are ‘one-size-fits-all’ vaccines that are useful for all people. But what if each and every person’s flu, like each person’s melanoma, was unique? You’d need a personalized vaccine that was made and customized for each individual. Dr. Patrick Ott, Clinical Director of the Melanoma Center at the Dana-Farber Cancer Institute and lead researcher on the BJ's Wholesale Club-MRA Team Science Award, is conducting pioneering research to harness the power of personalized vaccines to combat melanoma.
Melanoma: What You Need to Know
By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 29 April 2018 In Science
Melanoma is the deadliest form of skin cancer. Rates of melanoma are rising rapidly, especially in younger people. In fact, cases of melanoma have tripled in the last 30 years, at a time when cancer rates for other common cancers have declined.
Do you know the answer to these top ten questions people ask about melanoma?
Melanoma Leaves a Mark – but Not Always the One You Think
By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 27 April 2018 In Melanoma Stories
Melanoma is no stranger to University of Delaware Senior Samantha Stinchcomb. In fact, this silent killer has been part of her life for the last 11 years – over half her life. She learned the hard way, at the sobering age of 13, that melanoma ‘isn’t just skin cancer’ when her father lost his three year battle with the disease. Since then, Samantha has been diligent about her own skin – and has had 16 precancerous moles removed. “It took my father, my best friend, from this earth and my life. In the almost 8 years since my dad’s been gone,” said Samantha. “I’ve also learned melanoma doesn’t plan on getting out of my life anytime soon.”